2011 annual financial data
Sarepta Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -50.39%.
Operating income was -35,927,000 USD and net income was -2,318,000 USD.
Operating cash flow was -23,679,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 46,990,000 USD
- Operating income
- -35,927,000 USD
- Net income
- -2,318,000 USD
- Operating cash flow
- -23,679,000 USD